On behalf of Christian Kratzik, LLD, MD, meeting chairman, we are pleased to invite you to the Expert Practice^SM in Genitourinary Malignancies meeting in Vienna, Austria, on 23 October 2010.

During this case-based meeting, leaders in the field will discuss, in an interactive format, clinical issues encountered daily by practicing oncologists.

This activity is designed for medical oncologists, radiation oncologists, surgical oncologists, urologists, and other specialists actively involved in the management of patients with genitourinary malignancies.

The Imperial Riding School Vienna, A Renaissance Hotel
60 Ungargasse
1030 Vienna, Austria

Chair
Christian Kratzik, LLD, MD
University of Vienna
Vienna, Austria


Faculty
Marc Colombel, MD, PhD
Hospital Edouard Herriot
Lyon, France

Karim Fizazi, MD, PhD
Institut Gustave Roussy
Villejuif, France

Stephane Oudard, MD, PhD
Georges Pompidou Hospital
Paris, France

Alain Ravaud, MD, PhD
Hospital Saint Andre CHU
Bordeaux, France

Felix Sedlmayer, MD
SALK and Paracelsus Medical University
Salzburg, Austria

Friday, 22 October 2010

20.00

Reception and buffet dinner

Saturday, 23 October 2010

 

09.00	Welcome, introduction and demographic questions Lee Lokey, MD, Senior Medical Director prIME Oncology
09.20	What’s new in genitourinary radiation oncology? Felix Sedlmayer, MD
09.40	Case #1—Intermediate-risk organ-confined prostate cancer: Do we know what’s best? Discussants: Christian Kratzik, LLD, MD Felix Sedlmayer, MD
10.20	Case #2—Hormone-responsive prostate cancer: Optimal approach to metastatic disease Marc Colombel, MD, PhD
11.00	Break
11.20	Case #3—Castration-resistant prostate cancer: Making sense of diverse options Karim Fizazi, MD, PhD
12.00	Case #4—Carcinoma of the bladder: Which multidisciplinary approach should we choose? Panel Discussion Commentary: Karim Fizazi, MD, PhD
12.40	Clinical opinion poll
13.10	Lunch
14.10	Case #5—Renal cell carcinoma (RCC): Are adjuvant or neoadjuvant strategies ready for prime time? Stephane Oudard, MD, PhD
14.50	Case #6—Advanced RCC: A rational approach to choice of first-line therapy Discussant:    Alain Ravaud, MD, PhD Commentary: Stephane Oudard, MD, PhD
15.30	Case #7—Sequencing systemic therapy for metastatic RCC: Does one algorithm fit all? Alain Ravaud, MD, PhD
16.10	Concluding remarks